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Abstract
The aim of this study was to investigate augmented pain processing in the cortical somato-
sensory system in patients with fibromyalgia (FM). Cortical evoked responses were
recorded in FM (n = 19) and healthy subjects (n = 21) using magnetoencephalography after
noxious intra-epidermal electrical stimulation (IES) of the hand dorsum (pain rating 6 on a
numeric rating scale, perceptually-equivalent). In addition, healthy subjects were stimulated
using the amplitude corresponding to the average stimulus intensity rated 6 in patients with
FM (intensity-equivalent). Quantitative sensory testing was performed on the hand dorsum
or thenar muscle (neutral site) and over the trapezius muscle (tender point), using IES
(thresholds, ratings, temporal summation of pain, stimulus-response curve) and mechanical
stimuli (threshold, ratings). Increased amplitude of cortical responses was found in patients
with FM as compared to healthy subjects. These included the contralateral primary (S1)
and bilateral secondary somatosensory cortices (S2) in response to intensity-equivalent sti-
muli and the contralateral S1 and S2 in response to perceptually-equivalent stimuli. The
amplitude of the contralateral S2 response in patients with FM was positively correlated
with average pain intensity over the last week. Quantitative sensory testing results showed
that patients with FM were more sensitive to painful IES as well as to mechanical stimula-
tion, regardless of whether the stimulation site was the hand or the trapezius muscle. Inter-
estingly, the slope of the stimulus-response relationship as well as temporal summation of
pain in response to IES was not different between groups. Together, these results suggest
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that the observed pain augmentation in response to IES in patients with FM could be due to
sensitization or disinhibition of the cortical somatosensory system. Since the S2 has been
shown to play a role in higher-order functions, further studies are needed to clarify the role
of augmented S2 response in clinical characteristics of FM.
Introduction
Fibromyalgia (FM) is commonly associated with chronic wide-spread pain, but is notorious for
its multi-modal symptoms such as anxiety and depression, sleep disturbances, fatigue and cog-
nitive symptoms [1]. Typically, patients report pain upon palpation of pre-defined tender
point sites, and the number of painful tender points (at least 11 out of 18) has been commonly
used as a diagnostic criterion for FM (American College of Rheumatology, 1990) [2].
Previous studies of FM have shown that pain sensitivity [3–7], temporal summation of pain
[8–11], and cortical evoked responses [12–18] are generally increased in patients with FM as
compared to healthy control (HC) subjects, and that patients with FM often report longer and
different after-sensations [3, 8]. Moreover, patients with FMmay show reduced endogenous
pain inhibitory functions [5, 6, 19–21] and abnormal responses to innocuous somatosensory
[5, 22–24], auditory [25–27], and olfactory stimuli [28]. Together, these findings suggest that
sensory augmentation could be “generalized”, i.e. occurring at the central level and not being
specific for pain, although some inconsistencies remain [4, 29–31].
What remains largely unclear from studies assessing sensory symptoms and signs in
patients with FM is how different outcome measures relate to each other. This is particularly
important since patients with FM are notorious for their heterogeneity, and symptoms tend to
evolve over time. Also, the pathophysiology of FM, and in particular the relative contributions
of different pain mechanisms (e.g. increased facilitation and/or decreased inhibition) at differ-
ent neural levels (i.e. peripheral afferent, spinal cord and/or brain), remains a matter of debate
[1, 28, 32–34]. A better understanding of the mechanisms underlying pain augmentation may
help to develop pathophysiological models of FM and may contribute to improved diagnosis
and treatment.
With respect to the stimulation method, a recent magnetoencephalography (MEG) study
used painful and non-painful mechanical pressure stimuli that were subjectively matched
between patients with FM and HC subjects [17]. Since painful mechanical pressure stimulation
typically activates Aβ-, Aδ- and C-fibers, it is necessary to subtract the Aβ-fiber mediated
response to assess the pain-related brain response, as in previous functional magnetic reso-
nance imaging (MRI) studies in FM [13]. Otherwise, both intra-epidermal electrical stimula-
tion (IES) [35–40] and laser stimulation [41–44] have been regarded as validated methods for
selective activation of Aδ nociceptors in the epidermis. Prior MEG studies in combination with
IES [40, 45, 46] or laser stimulation [42–44, 47, 48] have reported activation of several brain
areas involved in the processing of the sensory-discriminative component of pain, such as the
primary (S1) and secondary (S2) somatosensory cortices and/or posterior parietal cortex
(PPC). Also recently, Mouraux et al. (2014) showed that trains of repeated IES with a short
inter-stimulus interval can be used to increase the intensity of perception and brain responses
[38].
The present study aimed to investigate the central augmentation of pain processing in
patients FM using MEG and IES which can selectively stimulate cutaneous Aδ nociceptors
[35]. Quantitative sensory testing was performed on the hand dorsum or thenar muscle (neu-
tral site) and over the trapezius muscle (tender point), using IES (thresholds, ratings, temporal
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summation of pain) and mechanical stimuli (threshold, ratings). In addition, the nature of pain
augmentation (e.g. higher offset and/or increased slope) was assessed using a stimulus-
response curve for standardized IES on the hand dorsum. Cortical pain processing of noxious
stimuli was prioritized for the estimation in the S1 and S2 [46].
Materials and Methods
Subjects
Subjects were right-handed (as confirmed by the Edinburgh Handedness Inventory) [49],
females and aged between 30 and 60 years (during which patients were more likely to be diag-
nosed as having primary FM). Subjects were excluded from participation if they presented with
contraindications for MEG and/or MRI assessment, pregnancy, a medical history of a psychiat-
ric disease or a disorder affecting the central nervous system (i.e. cerebrovascular accident,
multiple sclerosis, Parkinson’s disease), or signs of peripheral neuropathy of the upper extremi-
ties (e.g. related to trauma, polyneuropathy). Additional inclusion and exclusion criteria were
specified for patients and HC subjects separately as mentioned below.
Patients. Patients were recruited from the outpatient clinics of the rheumatology depart-
ments of the Seoul National University Hospital and Hallym University Sacred Heart Hospital.
Patients were eligible for participation if they were clinically diagnosed as having primary FM
(according to the American College of Rheumatology 1990 criteria [2] that are still commonly
used for research purposes [21, 23, 50, 51]), their disease duration was at least 3 months, they
reported an average pain intensity of at least 40 on a 0−100 mm visual analogue scale (VAS; 0
mm = no pain, 100 mm = worst pain imaginable) during the past week, and they were willing
to stop taking medications known to influence the somatosensory system (e.g. analgesics, anti-
depressants, anticonvulsants) at least 3 days prior to assessments. In addition to the general
exclusion criteria, patient-specific exclusion criteria were secondary FM, concomitant chronic
pain of other etiology (i.e. rheumatoid arthritis, osteoarthritis), concomitant acute pain in the
upper extremities (e.g. due to injury).
Healthy controls. HC subjects were recruited through local advertisements and were
matched for age and gender to the FM group. In addition to the general exclusion criteria, con-
trol-specific exclusion criteria were chronic pain complaints of any kind, and acute pain at the
time of the assessments.
Ethics. The study protocol was approved by the institutional review board at Seoul
National University Hospital (H-1107-013-367) and Hallym University Sacred Heart Hospital
(2011-I048) and the study was conducted in compliance with the Declaration of Helsinki. All
subjects received verbal information about the study protocol and signed the informed consent
form prior to participation.
Demographics and medical data
For all subjects, age (years), marital status (single, married, separated/divorced), education
(years), employment status (employed, unemployed/housewife), and medication use were reg-
istered. For patients with FM, the disease duration (since onset of wide-spread pain) and num-
ber of tender points (as assessed by the treating rheumatologist using manual palpation upon
inclusion) were registered. The tender point count was (re-)assessed by a trained rheumatolo-
gist from Seoul National University Hospital (H.W.K) in both patients and HC subjects using a
hand-held pressure algometer (Baseline Evaluation Instruments, Fabrication Enterprises, New
York, USA). In addition, subjects filled out the Fibromyalgia Impact Questionnaire (FIQ,
patients only) [52], Beck’s Anxiety Inventory (BAI) [53], Beck’s Depression Inventory (BDI)
[54], and Pittsburgh Sleep Quality Index (PSQI) [55].
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The intensity of average pain over the last week was assessed using a VAS. The qualitative
aspects of clinical pain perception were assessed using the short-form McGill pain question-
naire (SF-MPQ) [56].
Quantitative sensory testing
All tests were performed on the right (dominant) upper extremity (hand and trapezius muscle).
The test order was fixed. All tests were performed before MEG recordings.
Mechanical stimuli. The tactile detection threshold (TDT) was determined using 5
Semmes Weinstein monofilaments (sizes: 2.83, 3.61, 4.31, 4.56, 6.65; Baseline Evaluation
Instruments, Fabrication Enterprises, New York, USA). The filaments were applied at 2 loca-
tions over the hand dorsum and at 2 locations over the trapezius muscle. For each body region,
the TDT was defined as the smallest filament that could be perceived at each location. In addi-
tion, subjects rated the perceived painfulness of a standardized pinprick stimulus (PIN, 6.65
Semmes-Weinstein filament).
The pressure pain threshold (PPT) was determined using an experimenter-operated pres-
sure algometer (Baseline Evaluation Instruments, Fabrication Enterprises, New York, USA).
An in-house Teflon stimulation surface of 1 cm2 and a slope of 0.5 kg per second were used.
Subjects were instructed to keep their arm in zero degrees of shoulder abduction and 90 degrees
of elbow flexion. The PPT was then determined at 3 locations over the thenar eminence of the
hand and at 3 locations over the trapezius muscle [4, 57, 58]. In response to the increasing pres-
sure delivered by the experimenter, subjects were instructed to verbally indicate when they first
perceived the pressure as painful. The 3 PPTs for each body region were averaged for further
analysis.
For all mechanical thresholds, subjects rated the average perceived painfulness directly after
threshold determination using a numeric rating scale (NRS; 0 = no pain, 10 = worst pain imag-
inable). All mechanical stimuli were delivered by a trained experimenter.
Electrical stimuli. The electrical sensory thresholds were determined using an experi-
menter-operated Digitimer DS7AH, which is a high voltage constant current stimulator (Digi-
timer Ltd., United Kingdom), and an intra-epidermal electrode (Nihon-Kohden, Tokyo,
Japan) (pulse width: 1 ms) [36, 39]. The intra-epidermal electrode was placed over the skin
between the first and second meta-carpal bones of the hand dorsum (first assessment) or over
the skin overlying the trapezius muscle (second assessment). The electrical sensation threshold
(EST) was determined by manually increasing the stimulator current output in steps of 0.05
mA. The subject had to indicate verbally when she first perceived the stimulus (typically a faint
sensation). The electrical pain threshold (EPT) was determined by manually increasing the
stimulator current output in steps of 0.3 mA. The subject had to verbally indicate when she
first perceived the stimulus as being sharp and painful. The electrical pain tolerance threshold
(EPTT) was determined by manually increasing the stimulator current output in steps of 0.5
mA. The subject had to verbally indicate when she first perceived the stimulus as being very
sharp and painful, and was not willing to tolerate a higher stimulus amplitude. Prior to the
actual assessments, subjects were trained to determine these thresholds reliably at both loca-
tions. All thresholds were determined 3 times for each body region. After each third assess-
ment, subjects rated the average perceived painfulness using an NRS. Thresholds were
averaged for each body region separately for further analysis.
Stimulus-response curve. A series of 12 standardized IES were presented to each subject
on the hand dorsum. Stimulus intensities were 25%, 100%, 175% and 250% of the individual
EPT, and were presented in a semi-randomized order, so that all intensities were used 3 times.
The inter-stimulus interval was approximately 5–10 seconds. Subjects were asked to rate the
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pain intensity of each stimulus using an NRS. Ratings were averaged according to stimulus
intensity for further analysis.
Temporal summation of pain. Lastly, subjects were asked to rate the pain intensity of a
single IES and the pain intensity of the last IES in a 1 Hz pulse train of 5 pulses using an NRS.
Pulse trains were generated using Stim2 software (Compumedics Neuroscan, Charlotte, North
Carolina, USA). The stimulus intensity equaled the individual EPT. Each series of pulses (sin-
gle, train) was rated 3 times, and then averaged. Temporal summation of pain could not be
determined in 1 patient with FM due to technical problems.
MEG responses to IES
Experimental conditions. An intra-epidermal electrode connected to a Digitimer DS7AH
(Digitimer Ltd., United Kingdom) operated by Stim2 Software (Compumedics Neuroscan,
Charlotte, North Carolina, USA), was used to apply single pulse IES to the dorsum of the right
hand [35]. A pulse width of 1 ms was used.
For patients, the stimulus intensity (mA) corresponded to moderately painful stimulation
with a perceptual pain rating of 6 on the NRS. This was determined after assessing electrical
quantitative sensory testing (QST) on the hand, by manually increasing the stimulator current
output in steps of 0.3 mA. For HC subjects, a perceptually-equivalent (HC-PE) stimulus and
an intensity-equivalent (HC-IE) stimulus were used. For HC-PE, the stimulus intensity corre-
sponded to moderately painful stimulation with a perceptual pain rating of 6 on the NRS, and
it was determined for each subject individually as described for patients with FM. For HC-IE,
the stimulus intensity was fixed at 2.66 mA, corresponding to the stimulus intensity necessary
to evoke an average pain rating of 6 on the NRS in patients with FM (n = 7). The order of the
stimulus condition (HC-IE or HC-PE) was randomized across subjects.
For each stimulus condition, a total number of 100 trials were recorded. The inter-stimulus
interval was 4–6 seconds (randomized). Subjects were instructed not to pay attention to the sti-
muli and to fix their gaze on a cross in the center of the front wall.
MEG recordings. The MEG signals were recorded in a magnetically shielded room using
a helmet-shaped whole-head neuromagnetometer with a sensor array of 102 identical triple
sensors (VectorViewTM, Elektra Neuromag Oy, Helsinki, Finland). Each sensor consisted of 2
orthogonal planar gradiometers and 1 magnetometer. Subjects were seated comfortably under
the helmet-shaped sensor array. The exact location of the head relative to the sensor array was
determined by placing 4 head position indicator coils at known sites on the scalp, and the mag-
netic signal produced by electrical currents delivered to each of these 4 head position indicator
coils was subsequently measured. The location of the head position indicator coils relative to 3
anatomical landmarks, the nasion and the 2 preauricular points, was measured using a
3-dimensional digitizer (FASTRAKTM, Polhemus, Colchester, Vermont, USA). In this way,
MEG and MRI coordinate systems could be aligned [59]. The x-axis passed through the 2 pre-
auricular points (right = positive), the y-axis (positive) passed through the nasion, and the z-
axis (positive) pointed upward. High-resolution T1-weighted MR images were obtained from
all subjects, except for one control subject due to claustrophobia, using a Siemens 3 T scanner
(Siemens Magnetom TrioTim, Siemens, Erlangen, Germany).
The MEG signals were recorded with a band-pass filter of 0.1–300 Hz and were digitized at
1 kHz. Environmental and biological noises were reduced by applying the spatiotemporal
space separation method to the acquired MEG signals using MaxFilter software version 2.2.10
(Elekta Neuromag Oy, Helsinki, Finland) [60].
MEG analysis. Epochs with amplitudes exceeding 3000 fT/cm (MEG) or 150 μV (electro-
oculogram) during the time window for analysis (100 ms pre-stimulus to 400 ms post-
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stimulus) were excluded from the analysis. All remaining epochs were averaged according to
the stimulation intensity level. A minimum of 80 epochs were needed for subjects to be
included in the analyses.
Source modeling was based on the signals recorded by the 204 gradiometers in individual
subjects in response to NRS6 (patients) and HC-PE (HC subjects) stimulation. The cortical
sources were modelled in the time domain as equivalent current dipoles (ECD), using Elekta
Neuromag software (Elekta Neuromag Oy, Helsinki, Finland) [59]. A spherical volume con-
ductor was used to model the head. For the subject in whom brain MRI was not available, a
sphere model was fitted to accurately digitized isotrak points using MaxFilter software [61].
The ECDs that best explained the measured data were determined by a least-squares search at
the latency of the peak amplitude, using a subset of 18–24 gradiometer channels over the maxi-
mum response area. This resulted in the respective three-dimensional location, orientation and
strength of the ECDs in a spherical volume conductor model of the head. Only ECDs with a
goodness-of-fit  80% of the field variance were accepted for further analysis [47, 62].
A source corresponding to the contralateral S1 (cS1) was found in 14 FM and 15 HC sub-
jects. Sources corresponding to the contralateral secondary (cS2) and ipsilateral secondary
(iS2) somatosensory cortex were found in all but one FM subject. A source corresponding to
the contralateral PPC was found in 2 FM and 2 HC subjects. For the subject in whom brain
MRI was not available, sources were identified by considering coordinates, peak latencies and
orientations of the modelled sources. After identifying the single dipoles for each subject, the
entire time window for analysis and all channels were taken into account for computing an
individual time-varying multi-dipole model with fixed ECDs. For those subjects in whom a
PPC source was identified, this source was included in the multi-dipole model to improve its
goodness-of-fit. However, no further analysis relating to PPC activation was performed since
only 2 PPC data sets would be available per group. For HC subjects, the sources estimated
based on the HC-PE condition were applied to the signals recorded for the HC-IE condition
[63]. For each subject and stimulation intensity level, the response peak latencies and ampli-
tudes of the ECDs corresponding to the cS1, cS2 and iS2 sources were determined and used for
further analysis.
Individual MRIs were spatially normalized to the Talairach coordinates using BrainVoyager
QX software (version 1.10; Brain Innovation, Maastricht, The Netherlands) according to Lim
et al. 2011 and 2015 [23, 64]. Locations of the cS1, cS2 and iS2 sources in the head coordinates
were transformed into Talairach coordinates using Brain Electrical Source Analysis software
(version 5.1.8; MEGIS software, Munich, Germany). Twenty HC subjects whose MRI data
were available were included in deriving the source location in the Talairach coordinates.
Statistical analysis
All statistical testing was performed using SPSS 13.0 for Windows (SPSS Inc. Chicago, IL,
USA).
Demographic and medical data. For all demographic and medical data and pain assess-
ments, frequencies (binary data) or averages and standard deviations (continuous data) were
calculated for each group, and compared using appropriate statistical tests (independent t-tests
and X2-tests). All tests were 2-tailed. A p-value less than 0.05 was considered statistically
significant.
Quantitative sensory testing. QST parameters (thresholds, ratings, stimulus-response
curve, temporal summation of pain) were generally not normally distributed. As such, median
and range were calculated for thresholds and threshold ratings. For presentation purposes, the
stimulus-response curves and results for temporal summation of pain are presented using
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mean ± SEM. Prior to statistical analyses, all individual raw QST parameters were log-trans-
formed to allow for testing under normality assumptions [58].
For QST thresholds and ratings (TDT, PIN, PPT, EST, EPT, EPTT), differences between
groups were statistically tested using repeated measures analyses of variance (ANOVA) with
factors [Site] (hand, trapezius muscle) and [Group] (FM, HC). For the stimulus-response
curve, ratings for the series of fixed stimulus amplitudes at 25%, 100%, 175% and 250% of the
EPT were compared between groups using a repeated measures ANOVA with factors [Inten-
sity] (25%, 50%, 100%, 175%) and [Group] (FM, HC). For temporal summation of pain, the
ratings for the single pulse and pulse train stimulation at 100% of the EPT, were compared
between groups using a repeated measures analysis with factors [Number of pulses] (1, 5) and
[Group] (FM, HC). Differential effects of temporal summation of pain were tested as interac-
tions between the number of pulses and group as in a previous study [10]. The influence of
potential confounders was assessed using additional multivariate analyses with dependent
[QST threshold and/or rating] (TDT, PIN, PPT, EST, EPT, EPTT), factor [Group] (FM, HC)
and covariate [potential confounder] (BAI, BDI, PSQI). All factors were entered into the analy-
ses separately. Although the covariates BDI (PPT) and PSQI (TDT, EST) were significant upon
multivariate testing, associations for independent testing were not consistent. Moreover, in all
cases, a significant effect of [Group] remained. We therefore considered systematic confound-
ing by any of these variables highly unlikely.
MEG data. The peak latencies and amplitudes of the bilateral S2 sources were analysed
using repeated measures ANOVA with a within-subjects factor [Source] (cS2, iS2) and between-
subjects factor [Group] (FM, HC-IE or HC-PE). Mauchly's test of sphericity was used to evaluate
the assumption of sphericity. Significant between-subjects effects were further tested using inde-
pendent t-tests. The between-group differences in peak latencies and amplitudes of the cS1
source were compared by independent t-tests with factor [Group] (FM, HC-IE or HC-PE).
Talairach coordinates of the cS1, cS2 and iS2 sources were compared separately by means of
repeated measures ANOVA with coordinate (x, y and z) as a within-subject factor and group
(FM and HC) as a between-subject factor. The relationship between the amplitude of cortical
responses and FM pain intensity as reported for the last week (VAS) was assessed using Pearson’s
correlation coefficient (r). The influence of potential confounders on bilateral S2 source ampli-
tudes was assessed using a multivariate analysis with a dependent variables [cS2, iS2], factor
[Group] (FM, HC-IE or HC-PE) and covariate [potential confounder] (BAI, BDI and PSQI). All
factors were entered into the analyses separately. There were no significant effects for any of the
covariates. The influence of potential confounders on cS1 source amplitudes was assessed using a
multivariate analysis with dependent variable [cS1], factor [Group] (FM, HC-IE or HC-PE) and
covariate [potential confounder] (BAI, BDI and PSQI). All factors were entered into the analyses
separately. Although the covariate BAI was significant, the significant effect of [Group] remained.
In summary, it is unlikely that the amplitudes of cortical sources were confounded by group dif-
ferences in clinical variables relating to anxiety, depression or sleep quality.
Results
A total of 19 patients with FM and 21 HC subjects participated in the experiments.
Demographics & medical data
A summary of demographics and medical data is presented in Table 1. Patients with FM
showed higher anxiety scores (BAI), higher depression scores (BDI), reduced sleep quality
(PSQI) (p< 0.001), and an increased number of painful tender points upon manual palpation
or pressure algometry (p< 0.001).
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Quantitative sensory testing
Thresholds and ratings. A summary of the median and range of thresholds and ratings as
obtained with QST is presented in Table 2. For all subjects, TDT thresholds were found to be
within the normal range (Semmes Weinstein filament sizes 3.61 or 4.31) and were not analysed
further. Statistical analyses revealed significant differences between groups, indicating that
QST thresholds (PPT, EPT, EPTT) were lower and QST ratings (PIN, PPT, EST, EPT, EPTT)
were higher in patients with FM as compared to HC subjects. With respect to the 2 stimulation
sites, the PPT was found to be significantly lower (p< 0.001) and the PIN rating was signifi-
cantly higher (p = 0.003) for stimulation of the trapezius muscle. No significant interaction
effects were found (p> 0.05), suggesting that the effect of [Site] was similar in both groups.
Stimulus-response curve. The mean NRS scores corresponding to fixed levels of IES are
presented for both groups in Fig 1A. Statistical analysis showed that, compared to HC subjects,
patients with FM rated the stimuli as more painful (p = 0.006). In both groups, NRS ratings
increased when stimulus intensity was increased (p< 0.001). No significant interaction effects
were found (p = 0.099), suggesting that this effect of stimulus intensity was similar in both
groups.
Temporal summation of pain. Fig 1B presents the NRS ratings in response to standard-
ized electrical stimulation with 1 and 5 pulses. Statistical analysis showed that, compared to
HC subjects, patients with FM rated the stimuli as more painful (p = 0.009). In both groups,
NRS ratings increased when the number of pulses was increased (p = 0.001). No significant
interaction effects were found (p = 0.315). As such, the effect of the number of pulses was
Table 1. Demographics and clinical characteristics of the participants.
FM (n = 19) HC (n = 21) p [Group]
Age (years) 44.9 ± 8.3 44.8 ± 8.2 0.958
Education (years) 13.1 ± 2.2 12.9 ± 2.7 0.853
Occupation (working), n (%) 10 (53%) 13 (62%) 0.554
Marital status (married), n (%) 16 (84%) 17 (81%) 0.787
Medication, n (%)
Analgesics/muscle relaxants/NSAIDs 14 (74%) − −
Antidepressants 14 (74%) − −
Anticonvulsants 7 (37%) − −
BAI (0–63) 23.3 ± 10.8 1.8 ± 2.0 <0.001
BDI (0–63) 19.0 ± 6.8 2.8 ± 3.9 <0.001
PSQI (0–21) 13.0 ± 3.4 3.1 ± 1.2 <0.001
TP manual (0–18) 15.7 ± 1.8 1.7 ± 2.3 <0.001
TP algometer (0–18) 14.2 ± 3.8 1.9 ± 1.7 <0.001
FIQ (0–100) 62.5 ± 13.2 − −
Pain duration (months) 35.6 ± 31.1 − −
Pain intensity—last week (mm) 57.2 ± 20.1 − −
SF-MPQ sensory (0–33) 14.7 ± 6.8 − −
SF-MPQ affective (0–12) 5.8 ± 2.6 − −
SF-MPQ total (0–45) 20.5 ± 8.8 − −
Data are presented as mean ± SD or number of subjects (%). Pain intensity (visual analog scale) was determined before QST and MEG assessments.
FM: ﬁbromyalgia, HC: healthy controls, NSAIDs: nonsteroidal anti-inﬂammatory drugs, BAI: Beck’s anxiety inventory, BDI: Beck’s depression inventory,
PSQI: Pittsburgh sleep quality index, TP: tender points, FIQ: ﬁbromyalgia impact questionnaire, SF-MPQ: short-form McGill pain questionnaire. p-values
are based on independent t-tests (continuous variables) and X2-tests (categorical variables) with factor [Group]. Signiﬁcant p-values (p < 0.05) are
depicted in bold type.
doi:10.1371/journal.pone.0151776.t001
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similar in both groups, suggesting that temporal summation of pain in patients with FM was
comparable to that in HC subjects.
MEG responses to IES
The mean stimulus intensity in patients with FM was 2.89 ± 0.89 mA (NRS6). The mean stimu-
lus intensity in HC subjects was 5.60 ± 1.95 mA (NRS6 = HC-PE). Stimulus intensities for NRS
6 were significantly lower in patients with FM as compared to HC subjects (t = 5.562,
p< 0.001). Fixed stimulus intensity of 2.66 mA in HC-IE was comparable to mean stimulus
intensity in patients with FM (2.89 ± 0.89 mA, NRS6).
The spatial distribution of the somatosensory evoked fields in response to noxious IES of
the right hand dorsum in representative FM (A) and HC (B) subjects is presented in Fig 2. In
all subjects, clear long-latency responses were observed in the contralateral parietal area (Fig 2,
insert a) and the bilateral temporoparietal areas (Fig 2, insert b and c). These responses could
be located in the posterior wall of the central sulcus corresponding to the location of S1, and in
the upper bank of the bilateral Sylvian fissure corresponding to S2, respectively. The averaged
MEG data of all subjects is in S1 Dataset (see S1 Table for description).
Table 2. Quantitative sensory testing.
Test Site Outcome FM (n = 19) HC (n = 21) p [Group] p [Site]
TDT H Rating (0–10) 0 [0–0] 0 [0–0] 0.134 0.134
T Rating (0–10) 0 [0–1] 0 [0–0]
PIN H Rating (0–10) 2 [0–5] 0 [0–3] <0.001 0.003
T Rating (0–10) 3 [0–7] 0 [0–3]
PPT H Threshold (kPa) 2.83 [1.53–4.73] 3.77 [2.70–4.50] <0.001 <0.001
Rating (0–10) 3 [1–6] 2 [1–4] 0.005 0.427
T Threshold (kPa) 2.10 [1.43–5.75] 3.17 [2.20–4.67]
Rating (0–10) 3 [1–7] 2 [0–4]
EST H Threshold (mA) 0.15 [0.10–0.27] 0.15 [0.10–0.28] 0.856 0.388
Rating (0–10) 0 [0–3] 0 [0–0] 0.004 0.131
T Threshold (mA) 0.15 [0.05–0.48] 0.15 [0.10–0.45]
Rating (0–10) 0 [0–1] 0 [0–0]
EPT H Threshold (mA) 1.00 [0.60–1.80] 1.30 [0.80–3.90] 0.004 0.097
Rating (0–10) 3 [1–5] 2 [1–4] 0.001 0.797
T Threshold (mA) 1.10 [0.60–2.80] 1.20 [0.80–3.50]
Rating (0–10) 3 [1–4] 1 [1–3]
EPTT* H Threshold (mA) 2.83 [1.83–6.00] 5.33 [2.50–8.50] <0.001 0.986
Rating (0–10) 6 [4–8] 4 [2–7] 0.003 0.320
T Threshold (mA) 2.50 [1.50–7.07] 5.08 [2.33–12.50]
Rating (0–10) 6 [3–8] 5 [3–7]
Data are presented as median [min—max]. FM: ﬁbromyalgia, HC: healthy controls, TDT: tactile detection threshold, PIN: pinprick stimulation, PPT:
pressure pain threshold, EST: electrical sensation threshold, EPT: electrical pain threshold, EPTT: electrical pain tolerance threshold, H: hand (dorsum or
thenar muscle), T: trapezius muscle.
*Some subjects did not report tolerance at the highest stimulation level. Since this occurred in both patients and controls alike, and since we did not set a
cut-off threshold (mA) for the forehand, it was decided to exclude these subjects from the EPTT analyses. As such, the ﬁnal number of subjects for the
EPTT analyses were: for the hand FM (n = 18), and for the trapezius muscle FM (n = 16) and HC (n = 16), and repeated measures ANOVA for the EPTT
was based on FM (n = 16) and HC (n = 16). For QST thresholds and ratings, p-values were based on univariate results of repeated measures ANOVA
using log-normalized data with factors [Group] and [Site]. Signiﬁcant p-values (p < 0.05) are depicted in bold type. No signiﬁcant interaction effects were
found.
doi:10.1371/journal.pone.0151776.t002
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Fig 3A shows the group mean location of the S1 and S2 dipole sources superimposed on the
standard brain (Table 3). The results showed a main effect of coordinate (cS1, p< 0.001; cS2,
p< 0.001; iS2, p< 0.001, respectively), whereas a main effect of group (cS1, p = 0.221; cS2,
p = 0.355; iS2, p = 0.120, respectively) and a coordinate x group interaction effect (cS1,
p = 0.242; cS2, p = 0.309; iS2, p = 0.103, respectively) were not observed. Fig 3B shows the
grand averaged source waveforms based on the multi-dipole models as calculated for each
group.
Fig 4 shows the mean ± SEM amplitudes of the cS1 and bilateral S2 responses in both
groups. For the amplitude of bilateral S2 responses, a significant main effect of group was
found on comparing FM to both the HC-PE (F(1, 37) = 4.762, p = 0.036) and the HC-IE (F(1,
37) = 12.533, p = 0.001) conditions. The amplitudes of the S2 sources were significantly greater
in patients with FM compared to HC subjects for both cS2 (HC-PE: t = 2.222, p = 0.032;
HC-IE: t = 3.343, p = 0.002) and iS2 (HC-IE: t = 3.052, p = 0.004). The amplitude of cS1
Fig 1. Stimulus-response curve (A) and temporal summation of pain (B) in response to standardized
intra-epidermal electrical stimulation.Grey squares/bars represent patients with FM (A: n = 19, B: n = 18),
white squares/bars represent HC subjects (n = 21). The levels of stimulation (x-axis) were based on individual
pain thresholds. PT_25%, PT_100%, PT_175% and PT_250% correspond to 25%, 100%, 175% and 250%
of the pain threshold intensity (mA), respectively. Data are expressed as the mean ± SEM.
doi:10.1371/journal.pone.0151776.g001
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Fig 2. Spatial distribution of the MEG responses in a representative FM (A) and HC subjects (B). The head is viewed from the top. The trace of each
gradiometer response pair represents the magnetic field derivation along the latitude (upper) and longitude (lower). The inserts on the right indicate the
enlarged responses recorded from the contralateral S1 (a), contralateral S2 (b) and ipsilateral S2 (c) regions. The black lines represent the cortical response
Pain Augmentation in Somatosensory Cortex in Fibromyalgia
PLOS ONE | DOI:10.1371/journal.pone.0151776 March 18, 2016 11 / 22
responses was significantly greater in patients with FM compared to HC subjects for both the
HC-PE (t = 2.496, p = 0.019) and HC-IE (t = 3.599, p = 0.001) conditions. Peak latencies of the
S1 and S2 sources (Table 4) were not different between groups.
to the NRS 6 (FM) and perceptually-equivalent (HC) conditions. The grey line represents the cortical response to the intensity-equivalent condition (HC only).
The vertical dotted lines indicate the stimulus onset.
doi:10.1371/journal.pone.0151776.g002
Fig 3. Groupmean source locations (A) and source waveforms (B). (A) The group mean source locations for the NRS6 condition (FM) in blue and for the
perceptually-equivalent condition (HC-PE) in cyan superimposed on a standard brain. (B) The group mean source waveform as a function of time. The NRS6
condition (FM) in blue, HC-PE in cyan and the intensity-equivalent condition (HC-IE) in gray. The vertical line indicates the stimulus onset.
doi:10.1371/journal.pone.0151776.g003
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The amplitude of the cS2 response was positively correlated to the clinical pain intensity
over the last week (r = 0.500, p = 0.035) (Fig 5). In an exploratory analysis, no significant corre-
lations were found between the amplitude of the cortical response and the sensory and affective
pain scores (SF-MPQ).
Table 3. Mean source locations for the NRS6 (FM) and perceptually-equivalent (HC-PE) conditions.
FM HC-PE
cS1 (n = 14) cS2 (n = 18) iS2 (n = 18) cS1 (n = 15) cS2 (n = 21) iS2 (n = 21)
Head coordinates, mm
x -32.0 ± 8.3 -42.5 ± 7.8 41.9 ± 6.2 -31.3 ± 8.6 -47.7 ± 7.8 47.5 ± 5.9
y 1.7 ± 8.0 14.4 ± 8.4 15.8 ± 8.2 -1.6 ± 7.1 12.9 ± 6.4 12.9 ± 6.8
z 85.1 ± 8.4 58.9 ± 6.8 60.2 ± 8.4 91.6 ± 7.3 59.5 ± 8.7 61.1 ± 6.7
Talairach coordinates, mm
x -34.4 ± 6.7 -46.8 ± 7.1 43.9 ± 7.0 -35.0 ± 8.7 -50.4 ± 7.2 50.2 ± 7.8
y -29.5 ± 9.5 -9.7 ± 6.4 -9.7 ± 8.0 -32.6 ± 10.6 -11.5 ± 8.2 -11.8 ± 6.2
z 45.5 ± 9.6 18.4 ± 7.1 21.0 ± 9.7 53.4 ± 6.0 20.6 ± 9.2 22.6 ± 8.0
GOF (%) 92.7 ± 5.8 92.4 ± 4.5 91.6 ± 5.6 90.4 ± 6.3 90.1 ± 5.7 91.3 ± 7.6
Data are expressed as the mean ± SD. Twenty HC subjects whose MRI data were available were included in deriving the source location in the Talairach
coordinates. FM: ﬁbromyalgia, HC: healthy controls, cS1: contralateral primary somatosensory cortex; cS2: contralateral secondary somatosensory cortex;
iS2: ipsilateral secondary somatosensory cortex; GOF: Goodness-of-ﬁt; n: number of subjects included in the analysis.
doi:10.1371/journal.pone.0151776.t003
Fig 4. The amplitudes of the cS1, cS2 and iS2 in patients with FM and HC subjects.Repeated measures ANOVAs and independent t-tests showed that
cortical responses in response to intra-epidermal electrical stimulation of the hand were higher in patients with FM as compared to both perceptually-
equivalent (HC-PE) and intensity-equivalent (HC-IE) conditions in HC subjects. Data are expressed as the mean ± SEM. *p < 0.05, **p < 0.01.
doi:10.1371/journal.pone.0151776.g004
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Discussion
The present study aimed to investigate the central augmentation of pain processing in patients
with FM using MEG and IES. Dipole amplitudes in the cS1, cS2 and iS2, were found to be
increased in patients with FM as compared to HC subjects, and the amplitude of the cS2
response in patients with FM was positively correlated to the clinical pain intensity reported
over the last week. In addition, QST findings showed that patients with FM were more sensitive
to painful IES as well as to mechanical stimulation, regardless of whether the stimulation site
was the hand or the trapezius muscle. Interestingly, the slope of the stimulus-response relation-
ship as well as temporal summation of pain in response to IES was not different between
groups, suggesting that the observed pain augmentation in response to IES in patients with FM
could be due to sensitization or disinhibition at the cortical level.
Quantitative sensory testing
Our findings showing no differences in tactile as well as electrical detection threshold between
the groups suggest that tactile sensitivity in patients with FM is generally normal. This result is
in line with several other studies that showed no differences between FM patients and HC sub-
jects in terms of tactile perception threshold [65] and electrical [66, 67] and mechanical detec-
tion threshold [4]. In contrast to the findings of tactile sensitivity, FM patients showed
increased pain sensitivity to IES as well as to mechanical stimulation, regardless of whether
they were stimulated at a tender point (trapezius) or a neutral site (hand), indicating the
Table 4. Peak latencies and peak amplitudes of the S1 and S2 sources.
Latency (ms) Amplitude (nAm)
cS1 cS2 iS2 cS1 cS2 iS2
FM 137.7 ± 28.7 129.5 ± 27.5 148.1 ± 28.5 20.4 ± 7.0 42.4 ± 21.3 36.1 ± 20.9
HC-PE 132.8 ± 26.5 120.8 ± 13.6 137.5 ± 23.4 15.1 ± 4.1 30.0 ± 13.1 26.4 ± 14.6
HC-IE 135.6 ± 29.2 125.0 ± 17.1 146.0 ± 22.1 12.6 ± 4.5 24.2 ± 12.2 20.2 ± 10.6
Data are expressed as mean ± SD. FM: ﬁbromyalgia; HC-PE: perceptually-equivalent condition in healthy controls; HC-IE: intensity-equivalent condition in
healthy controls; cS1: contralateral primary somatosensory cortex; cS2: contralateral secondary somatosensory cortex; iS2: ipsilateral secondary
somatosensory cortex.
doi:10.1371/journal.pone.0151776.t004
Fig 5. Relationship between the dipole amplitude in the cS2 and clinical pain intensity (VAS, mm).
doi:10.1371/journal.pone.0151776.g005
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absence of specific changes at tender points. However, the stimulus-response curve slope was
similar in patients with FM and HC subjects, suggesting that the increased pain sensitivity in
patients with FM was due to a higher offset in stimulus intensity perception, rather than being
intensity dependent. This is consistent with previous FM studies demonstrating a parallel left-
ward shift in the stimulus-response curve without a change in slope in response to painful heat
and pressure stimuli [65, 68]. These results confirm and extend previous work reporting
reduced pain thresholds and increased pain ratings in patients with FM in response to a variety
of different stimuli at different body sites [3–7, 22, 69, 70], and point towards central sensitiza-
tion or disinhibition. This finding is in contrast with several recent studies implicating a role
for peripheral abnormalities in the maintenance of FM [71, 72]. Although peripheral mecha-
nisms cannot be ruled out, our results suggest that peripheral sensitization is unlikely to explain
the observed pain augmentation in response to IES in our patients with FM.
In addition to sensory thresholds and ratings, we assessed temporal summation of pain in
response to IES, which could be considered as the electrical equivalent of a noxious pinprick
stimulus, as used in studies by the German Research Network on Neuropathic Pain [58]. Tem-
poral summation of pain refers to the increase in perception of pain with repetitive noxious sti-
muli (0.3 Hz) that is thought to be related to a frequency-dependent increase in the
excitability of spinal cord neurons, commonly known as wind-up [10, 73]. In the present
study, patients with FM reported higher ratings in response to single and repeated IES, but
temporal summation of pain was not significantly different from that observed in HC subjects.
This is consistent with several other studies which showed that patients with FM were not sig-
nificantly different from HC subjects when testing temporal summation of pain using pinprick
[4, 74, 75] or thermal stimuli [30], or when testing reflex responses to nociceptive electrical
stimulation [29]. In contrast, several other studies have reported increased temporal summa-
tion of pain in response to thermal stimuli [10, 11], and reduced reflex responses to nociceptive
electrical stimulation in patients with FM [6, 76]. These mixed results are likely due to clinical
heterogeneity of the FM symptoms and methodological differences in stimulation. It can be
argued that the use of pain thresholds for the assessment of temporal summation can be prob-
lematic due to the low pain thresholds commonly observed in patients with FM [30]. There-
fore, more carefully designed studies are needed to clarify the presence or absence of abnormal
temporal summation of pain in patients with FM.
What is interesting about the findings in our study as compared to those in other studies is
that we used the same type of stimulus (IES) for the assessment of temporal summation of
pain, sensory thresholds and ratings, and cortical responses. The lack of differences between
patients with FM and HC subjects with respect to temporal summation of pain in response to
IES as observed in this study raises questions about the role of spinal sensitization in explaining
the observed pain augmentation in response to IES in our patients with FM.
MEG responses to IES
After noxious stimulation of the skin, several cortical sources may be identified including the
S1, S2, insular, and anterior cingulate cortex [77]. These cortical sources are considered to be
part of the so-called ‘pain matrix’, a network of brain areas implicated in the processing of pain
[78]. To the best of our knowledge, this study is the first research to combine MEG and IES in
the assessment of patients with FM and several sources could be identified, including the bilat-
eral S2 and cS1. Increased activity in the cS2 and cS1 was observed in patients with FM when
compared to both perceptually and intensity controlled activation in HC subjects. This is con-
sistent with a previous MEG study that used subjectively matched painful pressure stimuli in
patients with FM and HC subjects [17]. Lower stimulus intensities were required to evoke pain
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in patients with FM. However, these lower stimulation intensities still resulted in increased
evoked fields in the somatosensory, temporal and parietal areas at short latencies, and in pre-
frontal areas at both short and long latencies in patients with FM as compared to HC subjects
[17]. Importantly, in our study, significantly increased activity in the ipsilateral S2 was
observed, an area that has recently been implicated in mediating clinical pain in patients with
FM [18]. Since the S2 has been shown to play a role in higher-order functions, such as attention
[79] and integration of nociceptive and non-nociceptive sensory input [80], further studies are
needed to clarify the role of augmented S2 response in clinical characteristics of FM.
Augmented cortical responses to nociceptive stimuli could be due to facilitation or disinhi-
bition of nociceptive input at multiple levels in the cortical pain matrix. For example, it has
been suggested that prolonged nociceptive input could lead to central sensitization and mal-
adaptive neuroplasticity within the somatosensory and motor systems [81]. In our study by uti-
lizing paired-pulse median nerve stimulation and MEG, we found that intracortical inhibition
in the S1 is compromised in FM patients [23]. In addition, a growing body of evidence has sug-
gested that deficits in endogenous inhibitory systems could play an essential role in FM [51,
82–84]. A recent functional MRI study demonstrated that activity of the rostral anterior cingu-
late cortex, known to play a crucial role in descending pain inhibition, was attenuated in
patients with FM upon painful pressure stimulation [82]. Moreover, patients with FM showed
reduced functional connectivity between the rostral anterior cingulate cortex and other regions
involved in the descending pain inhibitory network including the brainstem, rostral ventrome-
dial medulla, amygdala, and hippocampus [83]. Lastly, several previous studies assessing pain
augmentation in patients with FM have also reported decreased thalamic activation in response
to both painful [13] and non-painful [12] stimuli. As such, the observed pain augmentation in
the present study could have been due to altered filtering of nociceptive input in the thalamus.
Methodological considerations
In this study we used tools that have not been previously used (IES) or have been infrequently
(MEG) applied in the study of FM. The advantage of MEG is that cortical responses can be
measured in the time and space domain in great detail. However, only a subset of brain regions
involved in pain processing can be reliably detected using this method. To obtain information
about concomitant activation in other brain regions, other imaging methods as well as more
complex analysis procedures [17, 85] may complement the present results.
A particular strong point of our study was the assessment of cortical responses to IES in the
context of behavioral responses to the same type of stimulus. Still, in order to do so, different
levels of stimulation were used. Previous studies often used IES at or just above pain threshold
levels (<2.5 mA) [36, 37, 85], to ensure Aδ-fiber specific stimulation [37]. In some of our sub-
jects (including both patients and HC subjects), higher stimulus intensities were occasionally
needed, e.g. to assess the EPTT or to attain a perceptual pain rating of 6 on the NRS. This
means that the data cannot be contributed to the Aδ-fiber function alone. If IES activates Aδ-
and Aβ-fibers simultaneously, Aβ stimulation may have interfered with perception of pain elic-
ited by noxious stimuli. A study by Inui et al. found that cortical responses to noxious IES can
be inhibited by applying simultaneously innocuous transcutaneous electrical stimulation [86].
This effect may be more pronounced in case of HC-PE, where HC subjects required higher
stimulus intensities to induce moderate pain. However, systematic studies examining to what
extent the noxious evoked brain response was reduced by Aβ co-activation according to
increasing intensity of IES have not yet been performed. In addition, the subjective sensation of
the stimulus as well as the cortical response latencies comparable to those observed in studies
using lower stimulus intensities suggested a primary activation of Aδ-fibers. Markedly
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increased amplitudes of cS1, cS2 and iS2 responses in FM compared to HC-IE condition fur-
ther support our interpretation of pain augmentation in response to IES in FM. Taken together,
although our results cannot exclude the possibility that a higher intensity stimulus activates
other kinds of fibers, it is unlikely that this potential limitation affected the between-group dif-
ferences in response to IES. In the light of recent studies reporting C-fiber abnormalities in
patients with FM [71, 72], it could additionally be interesting to repeat the present study using
a recently developed modified version of the IES electrode that selectively stimulates C-fibers
[87].
Lastly, although the sample size in the present study was larger than that in previous clinical
MEG studies, the sample size was still relatively small considering the heterogeneous presenta-
tion of FM. In addition, the unknown effects of medication (or rather the medication stoppage
and limited washout period) limit the generalizability of the present results.
Conclusion
The present study investigated the central augmentation of pain processing in patients with
FM using MEG and IES. Increased responses were found in the cS1, cS2 and iS2 in patients
with FM, and the amplitude of the cS2 response was found to be positively correlated with clin-
ical FM pain intensity. These results corresponded with generalized hypersensitivity to both
IES and mechanical stimuli as assessed using QST. Temporal summation of pain in response
to IES was not different between patients with FM and HC subjects. Together, these results sug-
gest that the observed pain augmentation in response to IES in patients with FM occurred rela-
tively independent of peripheral and spinal sensitization to IES. The observed pain
augmentation in response to IES in patients with FM could be due to sensitization or disinhibi-
tion of the cortical somatosensory system. The combination of MEG and IES could therefore
be particularly useful to explore the role of bilateral somatosensory cortices in FM
pathophysiology.
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